Pfizer News
- All
- News
- Videos
-
US Health Department Pulls Back $500 Million In Funding mRNA Vaccines
The US Department of Health and Human Services is ending contracts to develop vaccines using messenger RNA technology, another step in the agency's changing practices toward vaccines under Secretary Robert F Kennedy Jr.
-
"Wish I Hadn't": US Anchor Megyn Kelly's Big Claim On Pfizer Covid Vaccine
American journalist Megyn Kelly has claimed that she developed an "autoimmune condition" after taking two doses of the Pfizer COVID-19 vaccine and a follow-up booster in 2021.
-
Indian-American Ex-Pfizer Employee Charged With Insider Trading On Covid Pill
Indian-American former Pfizer Inc. employee, Amit Dagar, who was charged with insider trading and a conspiracy to commit insider trading last year, has been convicted by the US Attorney for the Southern District of New York.
-
Government Blocked Pfizer's Covid Vaccine, Claims KCR In New Attack
Telangana Chief Minister K Chandrashekar Rao has alleged that the Central government did everything possible to "forcefully" prevent import of COVID-19 vaccines from Pfizer, especially when people were ready to get the best vaccine.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
China To Distribute Pfizer Vaccine In Beijing As Covid Cases Surge: Report
As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.
-
EU Watchdog Reviews Adapted Pfizer Jab. Target: Omicron
Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
-
Pfizer Sets Up Asia's First Global Drug Development Centre In Chennai
In a significant move to bring critical research and development capabilities under one roof, pharmaceutical company Pfizer has set up a global drug development centre at the IIT Madras Research Park in Tamil Nadu's Chennai.
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
2 Babies In Hospital After Pfizer Shot Given By Mistake In Brazil: Report
Two newborns in Brazil were given coronavirus vaccine shots by mistake and had to be hospitalised, Brazilian media report.
-
Covid Vaccine Booster Shots Roll Out For Australians As Curbs Ease
Australia began administering booster shots of Pfizer's COVID-19 vaccine on Monday as millions of people in its largest city, Sydney, woke up to more freedom amid an accelerating immunisation drive.
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
-
Expert Group In Talks With Pfizer For Vaccine Supply: Health Minister
An expert group of the Indian government is in talks with global pharma major Pfizer over COVID vaccine supply, said Union Health Minister Mansukh Mandaviya on Friday.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
US Health Department Pulls Back $500 Million In Funding mRNA Vaccines
The US Department of Health and Human Services is ending contracts to develop vaccines using messenger RNA technology, another step in the agency's changing practices toward vaccines under Secretary Robert F Kennedy Jr.
-
"Wish I Hadn't": US Anchor Megyn Kelly's Big Claim On Pfizer Covid Vaccine
American journalist Megyn Kelly has claimed that she developed an "autoimmune condition" after taking two doses of the Pfizer COVID-19 vaccine and a follow-up booster in 2021.
-
Indian-American Ex-Pfizer Employee Charged With Insider Trading On Covid Pill
Indian-American former Pfizer Inc. employee, Amit Dagar, who was charged with insider trading and a conspiracy to commit insider trading last year, has been convicted by the US Attorney for the Southern District of New York.
-
Government Blocked Pfizer's Covid Vaccine, Claims KCR In New Attack
Telangana Chief Minister K Chandrashekar Rao has alleged that the Central government did everything possible to "forcefully" prevent import of COVID-19 vaccines from Pfizer, especially when people were ready to get the best vaccine.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
China To Distribute Pfizer Vaccine In Beijing As Covid Cases Surge: Report
As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.
-
EU Watchdog Reviews Adapted Pfizer Jab. Target: Omicron
Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
-
Pfizer Sets Up Asia's First Global Drug Development Centre In Chennai
In a significant move to bring critical research and development capabilities under one roof, pharmaceutical company Pfizer has set up a global drug development centre at the IIT Madras Research Park in Tamil Nadu's Chennai.
-
Made In India Covid Vaccines Better Than Pfizer, Moderna, Says Adar Poonawalla: Report
Serum Institute of India (SII) CEO Adar Poonawalla today claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna.
-
2 Babies In Hospital After Pfizer Shot Given By Mistake In Brazil: Report
Two newborns in Brazil were given coronavirus vaccine shots by mistake and had to be hospitalised, Brazilian media report.
-
Covid Vaccine Booster Shots Roll Out For Australians As Curbs Ease
Australia began administering booster shots of Pfizer's COVID-19 vaccine on Monday as millions of people in its largest city, Sydney, woke up to more freedom amid an accelerating immunisation drive.
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
-
Expert Group In Talks With Pfizer For Vaccine Supply: Health Minister
An expert group of the Indian government is in talks with global pharma major Pfizer over COVID vaccine supply, said Union Health Minister Mansukh Mandaviya on Friday.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
